Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices.
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association（2018）
摘要
The results showed that patients who received ramucirumab monotherapy started ramucirumab therapy later after diagnosis and were older than those who received ramucirumab in combination. Additionally, survival data suggest that outcomes observed in community oncology practices are similar to data from phase 3 clinical trials.
更多查看译文
关键词
Gastric cancer,Gastroesophageal junction cancer,Outcomes research,Overall survival,Ramucirumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要